Dr Stephen Thompson
Non-Executive Director (representing MRCF)
Stephen has two decades experience in the international venture capital industry, focused on the life sciences sector, as well as significant experience in biotech management and research. He is a founding partner of Brandon Capital Partners, now the pre-eminent life sciences VC firm in Australia, and manager of the MRCF. Previously in Australia Stephen worked with Bio Innovation SA and helped establish Terra Rossa Capital. Prior to this he was a Director of Apax Partners, a leading international private equity group based in London. Before joining Apax Partners, he worked in product development for Cantab Pharmaceuticals after spending ten years as a research immunologist in London and California. As well as his Auspherix board role he is a director of Elastagen P/L, Heart Metabolics Ltd, Vaxxas P/L, and a Council Member of the Australian Venture Capital Association Limited (AVCAL). Stephen has a PhD in Immunology from Kings College London and an MBA, specialising in Entrepreneurship, from Imperial College London. He is a Graduate of the Australian Institute of Company Directors.